Clinical trial
A Phase 1 Trial of BTM-3566 in Advanced Solid Tumors
NCT07266285 is registered in ClinicalTrials.gov with Bantam Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Trial of BTM-3566 in Advanced Solid Tumors
- Lead sponsor
- Bantam Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 10, 2025
- Completion date
- August 31, 2027
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumors